Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Laura Li Gagnon

3PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 01, 2026
Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Laura Li Gagnon, Claire N Harrison

|Mar 28, 2026
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Laura Li Gagnon, Andrea Duminuco, Fabio Stagno

|Feb 13, 2025
Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety.

Roberta Dunn, Edouard Long, Laura Li Gagnon

Pageof 1

Frequent Collaborators

2 joint publications

Claire N Harrison

1 joint publications

Roberta Dunn

1 joint publications

Edouard Long

1 joint publications

Yunfan Yang

1 joint publications

Andrea Duminuco

1 joint publications

Fabio Stagno

1 joint publications

Marta Sobas

1 joint publications

Mikhail Fominykh

1 joint publications

Lee-Yung Shih

1 joint publications

Adam Mead

Frequent Collaborators

2 joint publications

Claire N Harrison

1 joint publications

Roberta Dunn

1 joint publications

Edouard Long

1 joint publications

Yunfan Yang

Top Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

980
See more related videos

Top Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

15.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

980
See more related videos